FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
Contenu indisponible. Consultez la source originale.
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.